Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Theodore Karrison

Showing results (141-150 of 155) with videos related to

Pageof 16
Sort By:
Nature Biomedical Engineering|November 20, 2024
Clinical validation of a wearable ultrasound sensor of blood pressureSai Zhou, Geonho Park, Katherine Longardner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 27, 2023
Dose-Escalated Radiotherapy Alone or in Combination With Short-Term Androgen Deprivation for Intermediate-Risk Prostate Cancer: Results of a Phase III Multi-Institutional TrialDaniel J Krauss, Theodore Karrison, Alvaro A Martinez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 4, 2015
Randomized Phase Ib/II Study of Gemcitabine Plus Placebo or Vismodegib, a Hedgehog Pathway Inhibitor, in Patients With Metastatic Pancreatic CancerDaniel V T Catenacci, Melissa R Junttila, Theodore Karrison, et al.
Cancer Biology & Therapy|May 6, 2011
RON (MST1R) is a novel prognostic marker and therapeutic target for gastroesophageal adenocarcinomaDaniel V T Catenacci, Gustavo Cervantes, Soheil Yala, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 4, 2022
A Randomized Multi-institutional Phase II Trial of Everolimus as Adjuvant Therapy in Patients with Locally Advanced Squamous Cell Cancer of the Head and NeckCherie-Ann O Nathan, D Neil Hayes, Theodore Karrison, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 19, 2006
Gene expression profiles in acute myeloid leukemia with common translocations using SAGESanggyu Lee, Jianjun Chen, Guolin Zhou, et al.
Pediatrics|July 26, 2006
Impact of visual impairment on measures of cognitive function for children with congenital toxoplasmosis: implications for compensatory intervention strategiesNancy Roizen, Kristen Kasza, Theodore Karrison, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 2, 2013
Phase II study of the oral MEK inhibitor selumetinib in advanced acute myelogenous leukemia: a University of Chicago phase II consortium trialNitin Jain, Emily Curran, Neil M Iyengar, et al.
Cancer Discovery|November 25, 2020
Personalized Antibodies for Gastroesophageal Adenocarcinoma (PANGEA): A Phase II Study Evaluating an Individualized Treatment Strategy for Metastatic DiseaseDaniel V T Catenacci, Stephanie Moya, Samantha Lomnicki, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 8, 2020
Improved Survival Associated with Local Tumor Response Following Multisite Radiotherapy and Pembrolizumab: Secondary Analysis of a Phase I TrialJason J Luke, Benjamin E Onderdonk, Sandeep R Bhave, et al.
Pageof 16

Showing results (141-150 of 155) with videos related to

Sort By:
Pageof 16
Nature Biomedical Engineering|November 20, 2024
Clinical validation of a wearable ultrasound sensor of blood pressureSai Zhou, Geonho Park, Katherine Longardner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 27, 2023
Dose-Escalated Radiotherapy Alone or in Combination With Short-Term Androgen Deprivation for Intermediate-Risk Prostate Cancer: Results of a Phase III Multi-Institutional TrialDaniel J Krauss, Theodore Karrison, Alvaro A Martinez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 4, 2015
Randomized Phase Ib/II Study of Gemcitabine Plus Placebo or Vismodegib, a Hedgehog Pathway Inhibitor, in Patients With Metastatic Pancreatic CancerDaniel V T Catenacci, Melissa R Junttila, Theodore Karrison, et al.
Cancer Biology & Therapy|May 6, 2011
RON (MST1R) is a novel prognostic marker and therapeutic target for gastroesophageal adenocarcinomaDaniel V T Catenacci, Gustavo Cervantes, Soheil Yala, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 4, 2022
A Randomized Multi-institutional Phase II Trial of Everolimus as Adjuvant Therapy in Patients with Locally Advanced Squamous Cell Cancer of the Head and NeckCherie-Ann O Nathan, D Neil Hayes, Theodore Karrison, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 19, 2006
Gene expression profiles in acute myeloid leukemia with common translocations using SAGESanggyu Lee, Jianjun Chen, Guolin Zhou, et al.
Pediatrics|July 26, 2006
Impact of visual impairment on measures of cognitive function for children with congenital toxoplasmosis: implications for compensatory intervention strategiesNancy Roizen, Kristen Kasza, Theodore Karrison, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 2, 2013
Phase II study of the oral MEK inhibitor selumetinib in advanced acute myelogenous leukemia: a University of Chicago phase II consortium trialNitin Jain, Emily Curran, Neil M Iyengar, et al.
Cancer Discovery|November 25, 2020
Personalized Antibodies for Gastroesophageal Adenocarcinoma (PANGEA): A Phase II Study Evaluating an Individualized Treatment Strategy for Metastatic DiseaseDaniel V T Catenacci, Stephanie Moya, Samantha Lomnicki, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 8, 2020
Improved Survival Associated with Local Tumor Response Following Multisite Radiotherapy and Pembrolizumab: Secondary Analysis of a Phase I TrialJason J Luke, Benjamin E Onderdonk, Sandeep R Bhave, et al.
Pageof 16